Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash-to-Debt 1.29
NYSE:VAR's Cash-to-Debt is ranked lower than
58% of the 325 Companies
in the Global Medical Devices industry.

( Industry Median: 2.55 vs. NYSE:VAR: 1.29 )
Ranked among companies with meaningful Cash-to-Debt only.
NYSE:VAR' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.24  Med: 4.05 Max: N/A
Current: 1.29
Equity-to-Asset 0.41
NYSE:VAR's Equity-to-Asset is ranked lower than
70% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. NYSE:VAR: 0.41 )
Ranked among companies with meaningful Equity-to-Asset only.
NYSE:VAR' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.32  Med: 0.52 Max: 0.6
Current: 0.41
0.32
0.6
Interest Coverage 34.35
NYSE:VAR's Interest Coverage is ranked lower than
58% of the 222 Companies
in the Global Medical Devices industry.

( Industry Median: 86.37 vs. NYSE:VAR: 34.35 )
Ranked among companies with meaningful Interest Coverage only.
NYSE:VAR' s Interest Coverage Range Over the Past 10 Years
Min: 34.35  Med: 100.85 Max: 226.41
Current: 34.35
34.35
226.41
Piotroski F-Score: 6
Altman Z-Score: 4.60
Beneish M-Score: -2.44
WACC vs ROIC
6.85%
21.05%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 13.73
NYSE:VAR's Operating Margin % is ranked higher than
80% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 2.62 vs. NYSE:VAR: 13.73 )
Ranked among companies with meaningful Operating Margin % only.
NYSE:VAR' s Operating Margin % Range Over the Past 10 Years
Min: 13.73  Med: 20.48 Max: 22.67
Current: 13.73
13.73
22.67
Net Margin % 9.38
NYSE:VAR's Net Margin % is ranked higher than
77% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 1.55 vs. NYSE:VAR: 9.38 )
Ranked among companies with meaningful Net Margin % only.
NYSE:VAR' s Net Margin % Range Over the Past 10 Years
Min: 9.38  Med: 14.03 Max: 15.36
Current: 9.38
9.38
15.36
ROE % 18.00
NYSE:VAR's ROE % is ranked higher than
89% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 1.31 vs. NYSE:VAR: 18.00 )
Ranked among companies with meaningful ROE % only.
NYSE:VAR' s ROE % Range Over the Past 10 Years
Min: 18  Med: 27.57 Max: 31.67
Current: 18
18
31.67
ROA % 8.02
NYSE:VAR's ROA % is ranked higher than
82% of the 327 Companies
in the Global Medical Devices industry.

( Industry Median: 0.06 vs. NYSE:VAR: 8.02 )
Ranked among companies with meaningful ROA % only.
NYSE:VAR' s ROA % Range Over the Past 10 Years
Min: 8.02  Med: 14.94 Max: 16.54
Current: 8.02
8.02
16.54
ROC (Joel Greenblatt) % 55.23
NYSE:VAR's ROC (Joel Greenblatt) % is ranked higher than
89% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 4.26 vs. NYSE:VAR: 55.23 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
NYSE:VAR' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 55.23  Med: 95.9 Max: 112.94
Current: 55.23
55.23
112.94
3-Year Revenue Growth Rate 7.80
NYSE:VAR's 3-Year Revenue Growth Rate is ranked higher than
63% of the 237 Companies
in the Global Medical Devices industry.

( Industry Median: 4.40 vs. NYSE:VAR: 7.80 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
NYSE:VAR' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -27.1  Med: 10.95 Max: 17.4
Current: 7.8
-27.1
17.4
3-Year EBITDA Growth Rate 3.00
NYSE:VAR's 3-Year EBITDA Growth Rate is ranked lower than
55% of the 208 Companies
in the Global Medical Devices industry.

( Industry Median: 5.10 vs. NYSE:VAR: 3.00 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
NYSE:VAR' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -47.6  Med: 12.4 Max: 65.2
Current: 3
-47.6
65.2
3-Year EPS without NRI Growth Rate 1.70
NYSE:VAR's 3-Year EPS without NRI Growth Rate is ranked higher than
51% of the 203 Companies
in the Global Medical Devices industry.

( Industry Median: 1.40 vs. NYSE:VAR: 1.70 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
NYSE:VAR' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -58.5  Med: 14.85 Max: 113.8
Current: 1.7
-58.5
113.8
GuruFocus has detected 5 Warning Signs with Varian Medical Systems Inc $NYSE:VAR.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NYSE:VAR's 10-Y Financials

Financials (Next Earnings Date: 2017-07-26 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

VAR Guru Trades in Q1 2016

Leucadia National 3,900 sh (New)
Joel Greenblatt 253,227 sh (+4147.35%)
First Eagle Investment 3,197,123 sh (+144.88%)
Ray Dalio 106,243 sh (+113.53%)
CI Can Am Small Cap 59,255 sh (+0.56%)
George Soros Sold Out
Paul Tudor Jones Sold Out
Jeremy Grantham Sold Out
Charles Brandes 177,421 sh (-2.42%)
Westport Asset Management 255,300 sh (-8.00%)
Jim Simons 83,382 sh (-57.28%)
David Rolfe 5,075 sh (-83.99%)
» More
Q2 2016

VAR Guru Trades in Q2 2016

Paul Tudor Jones 7,408 sh (New)
John Rogers 23,467 sh (New)
First Eagle Investment 4,325,749 sh (+35.30%)
Leucadia National Sold Out
Jim Simons Sold Out
Joel Greenblatt Sold Out
David Rolfe Sold Out
Westport Asset Management 250,300 sh (-1.96%)
Charles Brandes 169,029 sh (-4.73%)
Ray Dalio 44,400 sh (-58.21%)
» More
Q3 2016

VAR Guru Trades in Q3 2016

Richard Pzena 2,998 sh (New)
Steven Cohen 10,500 sh (New)
Jim Simons 11,500 sh (New)
Columbia Wanger 398,000 sh (New)
Paul Tudor Jones 8,463 sh (+14.24%)
John Rogers 24,968 sh (+6.40%)
Ray Dalio Sold Out
First Eagle Investment 4,316,310 sh (-0.22%)
Charles Brandes 156,511 sh (-7.41%)
CI Can Am Small Cap 52,355 sh (-11.64%)
» More
Q4 2016

VAR Guru Trades in Q4 2016

Joel Greenblatt 337,618 sh (New)
John Hussman 10,000 sh (New)
Paul Tudor Jones 18,666 sh (+120.56%)
Charles Brandes 163,536 sh (+4.49%)
First Eagle Investment 4,318,060 sh (+0.04%)
Steven Cohen Sold Out
Jim Simons Sold Out
Richard Pzena 2,860 sh (-4.60%)
Columbia Wanger 333,900 sh (-16.11%)
John Rogers 20,100 sh (-19.50%)
» More
» Details

Insider Trades

Latest Guru Trades with VAR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 334510    SIC: 3844
Compare:OTCPK:CNVVY, NYSE:TFX, OTCPK:SONVY, OTCPK:SDMHF, NAS:ALGN, OTCPK:CHEOY, OTCPK:WILLF, NAS:ABMD, NAS:MASI, OTCPK:EKTAF, OTCPK:FSPKF, NAS:NUVA, OTCPK:GNNDY, NAS:IART, NAS:WMGI, NYSE:GMED, NYSE:PEN, NYSE:NVRO, NAS:LIVN, NAS:ZLTQ » details
Traded in other countries:VNM.Germany,
Headquarter Location:USA
Varian Medical Systems Inc manufactures medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Varian Medical Systems designs, manufactures, and sells radiation technology for use within three business segments: oncology systems (76% of sales), X-ray products (19%), and other, mainly protons. The Americas account for the largest portion of revenue (50%), followed by Europe, the Middle East, and Africa, or EMEA (30%), and Asia-Pacific (20%).

Ratios

vs
industry
vs
history
PE Ratio 29.27
VAR's PE Ratio is ranked higher than
55% of the 177 Companies
in the Global Medical Devices industry.

( Industry Median: 27.53 vs. VAR: 29.27 )
Ranked among companies with meaningful PE Ratio only.
VAR' s PE Ratio Range Over the Past 10 Years
Min: 10.77  Med: 18.35 Max: 29.27
Current: 29.27
10.77
29.27
Forward PE Ratio 21.88
VAR's Forward PE Ratio is ranked higher than
52% of the 111 Companies
in the Global Medical Devices industry.

( Industry Median: 21.79 vs. VAR: 21.88 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 28.01
VAR's PE Ratio without NRI is ranked higher than
54% of the 175 Companies
in the Global Medical Devices industry.

( Industry Median: 27.51 vs. VAR: 28.01 )
Ranked among companies with meaningful PE Ratio without NRI only.
VAR' s PE Ratio without NRI Range Over the Past 10 Years
Min: 9.86  Med: 18.17 Max: 28.28
Current: 28.01
9.86
28.28
Price-to-Owner-Earnings 51.29
VAR's Price-to-Owner-Earnings is ranked lower than
69% of the 107 Companies
in the Global Medical Devices industry.

( Industry Median: 32.96 vs. VAR: 51.29 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
VAR' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 13.91  Med: 21.26 Max: 51.74
Current: 51.29
13.91
51.74
PB Ratio 6.58
VAR's PB Ratio is ranked lower than
70% of the 298 Companies
in the Global Medical Devices industry.

( Industry Median: 3.11 vs. VAR: 6.58 )
Ranked among companies with meaningful PB Ratio only.
VAR' s PB Ratio Range Over the Past 10 Years
Min: 2.71  Med: 4.48 Max: 8.1
Current: 6.58
2.71
8.1
PS Ratio 2.69
VAR's PS Ratio is ranked higher than
56% of the 296 Companies
in the Global Medical Devices industry.

( Industry Median: 3.20 vs. VAR: 2.69 )
Ranked among companies with meaningful PS Ratio only.
VAR' s PS Ratio Range Over the Past 10 Years
Min: 1.43  Med: 2.57 Max: 4.16
Current: 2.69
1.43
4.16
Price-to-Free-Cash-Flow 29.78
VAR's Price-to-Free-Cash-Flow is ranked lower than
53% of the 112 Companies
in the Global Medical Devices industry.

( Industry Median: 27.61 vs. VAR: 29.78 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
VAR' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 12.87  Med: 19.86 Max: 41.24
Current: 29.78
12.87
41.24
Price-to-Operating-Cash-Flow 23.97
VAR's Price-to-Operating-Cash-Flow is ranked lower than
61% of the 140 Companies
in the Global Medical Devices industry.

( Industry Median: 20.26 vs. VAR: 23.97 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
VAR' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 10.2  Med: 15.92 Max: 32.79
Current: 23.97
10.2
32.79
EV-to-EBIT 18.71
VAR's EV-to-EBIT is ranked higher than
68% of the 275 Companies
in the Global Medical Devices industry.

( Industry Median: 24.54 vs. VAR: 18.71 )
Ranked among companies with meaningful EV-to-EBIT only.
VAR' s EV-to-EBIT Range Over the Past 10 Years
Min: 6  Med: 12 Max: 19.4
Current: 18.71
6
19.4
EV-to-EBITDA 16.34
VAR's EV-to-EBITDA is ranked higher than
64% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 19.31 vs. VAR: 16.34 )
Ranked among companies with meaningful EV-to-EBITDA only.
VAR' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.5  Med: 10.8 Max: 17.8
Current: 16.34
5.5
17.8
PEG Ratio 6.82
VAR's PEG Ratio is ranked lower than
76% of the 83 Companies
in the Global Medical Devices industry.

( Industry Median: 2.52 vs. VAR: 6.82 )
Ranked among companies with meaningful PEG Ratio only.
VAR' s PEG Ratio Range Over the Past 10 Years
Min: 0.67  Med: 1.19 Max: 10.3
Current: 6.82
0.67
10.3
Shiller PE Ratio 26.03
VAR's Shiller PE Ratio is ranked higher than
84% of the 50 Companies
in the Global Medical Devices industry.

( Industry Median: 49.41 vs. VAR: 26.03 )
Ranked among companies with meaningful Shiller PE Ratio only.
VAR' s Shiller PE Ratio Range Over the Past 10 Years
Min: 19.34  Med: 25.3 Max: 39.87
Current: 26.03
19.34
39.87
Current Ratio 1.59
VAR's Current Ratio is ranked lower than
74% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 2.38 vs. VAR: 1.59 )
Ranked among companies with meaningful Current Ratio only.
VAR' s Current Ratio Range Over the Past 10 Years
Min: 1.38  Med: 1.86 Max: 2.33
Current: 1.59
1.38
2.33
Quick Ratio 1.15
VAR's Quick Ratio is ranked lower than
72% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 1.79 vs. VAR: 1.15 )
Ranked among companies with meaningful Quick Ratio only.
VAR' s Quick Ratio Range Over the Past 10 Years
Min: 1.04  Med: 1.48 Max: 1.87
Current: 1.15
1.04
1.87
Days Inventory 127.04
VAR's Days Inventory is ranked higher than
51% of the 289 Companies
in the Global Medical Devices industry.

( Industry Median: 130.04 vs. VAR: 127.04 )
Ranked among companies with meaningful Days Inventory only.
VAR' s Days Inventory Range Over the Past 10 Years
Min: 75.59  Med: 97.51 Max: 127.04
Current: 127.04
75.59
127.04
Days Sales Outstanding 89.08
VAR's Days Sales Outstanding is ranked lower than
69% of the 272 Companies
in the Global Medical Devices industry.

( Industry Median: 68.94 vs. VAR: 89.08 )
Ranked among companies with meaningful Days Sales Outstanding only.
VAR' s Days Sales Outstanding Range Over the Past 10 Years
Min: 85.76  Med: 90.38 Max: 105.45
Current: 89.08
85.76
105.45
Days Payable 29.59
VAR's Days Payable is ranked lower than
73% of the 259 Companies
in the Global Medical Devices industry.

( Industry Median: 59.71 vs. VAR: 29.59 )
Ranked among companies with meaningful Days Payable only.
VAR' s Days Payable Range Over the Past 10 Years
Min: 29.59  Med: 38.92 Max: 41.88
Current: 29.59
29.59
41.88

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio 4.20
VAR's 3-Year Average Share Buyback Ratio is ranked higher than
98% of the 218 Companies
in the Global Medical Devices industry.

( Industry Median: -3.90 vs. VAR: 4.20 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
VAR' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -3.5  Med: 1.55 Max: 4.7
Current: 4.2
-3.5
4.7

Valuation & Return

vs
industry
vs
history
Price-to-Net-Current-Asset-Value 18.36
VAR's Price-to-Net-Current-Asset-Value is ranked lower than
79% of the 206 Companies
in the Global Medical Devices industry.

( Industry Median: 6.88 vs. VAR: 18.36 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
VAR' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 6.53  Med: 11.23 Max: 39.93
Current: 18.36
6.53
39.93
Price-to-Tangible-Book 8.53
VAR's Price-to-Tangible-Book is ranked lower than
68% of the 263 Companies
in the Global Medical Devices industry.

( Industry Median: 4.11 vs. VAR: 8.53 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
VAR' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 3.2  Med: 5.79 Max: 10.54
Current: 8.53
3.2
10.54
Price-to-Intrinsic-Value-Projected-FCF 1.63
VAR's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
69% of the 129 Companies
in the Global Medical Devices industry.

( Industry Median: 2.23 vs. VAR: 1.63 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
VAR' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.85  Med: 1.34 Max: 3.92
Current: 1.63
0.85
3.92
Price-to-Intrinsic-Value-DCF (Earnings Based) 1.96
VAR's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked higher than
52% of the 25 Companies
in the Global Medical Devices industry.

( Industry Median: 1.82 vs. VAR: 1.96 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 1.05
VAR's Price-to-Median-PS-Value is ranked lower than
51% of the 242 Companies
in the Global Medical Devices industry.

( Industry Median: 1.03 vs. VAR: 1.05 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
VAR' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.61  Med: 1.07 Max: 1.83
Current: 1.05
0.61
1.83
Price-to-Graham-Number 2.71
VAR's Price-to-Graham-Number is ranked lower than
59% of the 138 Companies
in the Global Medical Devices industry.

( Industry Median: 2.19 vs. VAR: 2.71 )
Ranked among companies with meaningful Price-to-Graham-Number only.
VAR' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.66  Med: 2.35 Max: 4.04
Current: 2.71
0.66
4.04
Earnings Yield (Greenblatt) % 5.34
VAR's Earnings Yield (Greenblatt) % is ranked higher than
80% of the 432 Companies
in the Global Medical Devices industry.

( Industry Median: 2.17 vs. VAR: 5.34 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
VAR' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 5.1  Med: 8.4 Max: 16.8
Current: 5.34
5.1
16.8
Forward Rate of Return (Yacktman) % 6.30
VAR's Forward Rate of Return (Yacktman) % is ranked lower than
60% of the 125 Companies
in the Global Medical Devices industry.

( Industry Median: 8.85 vs. VAR: 6.30 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
VAR' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 6.3  Med: 19.4 Max: 28.8
Current: 6.3
6.3
28.8

More Statistics

Revenue (TTM) (Mil) $3,120
EPS (TTM) $ 3.10
Beta0.82
Short Percentage of Float8.87%
52-Week Range $68.75 - 94.48
Shares Outstanding (Mil)93.45

Analyst Estimate

Sep17 Sep18
Revenue (Mil $) 3,066 3,123
EPS ($) 4.19 4.55
EPS without NRI ($) 4.19 4.55
EPS Growth Rate
(Future 3Y To 5Y Estimate)
9.08%
Dividends per Share ($)
» More Articles for NYSE:VAR

Headlines

Articles On GuruFocus.com
Varian Spotlights World-Leading Systems for Advanced Radiotherapy, Radiosurgery, Brachytherapy and P Apr 27 2017 
Varian Medical Systems Names New CFO Apr 05 2017 
Varian Medical Systems Establishes Direct Operation in South Africa Apr 04 2017 
Varian Medical Systems and Elekta Settle Patent Litigation Apr 03 2017 
Varian Medical Systems Schedules Second Quarter FY2017 News Release and Conference Call Mar 31 2017 
Varian Eclipse Customers Achieve Top Scores in International Treatment Plan Studies Mar 31 2017 
Columbia Wanger's Largest Trades in 3rd Quarter Nov 11 2016 
The 'Bribing the Purchasing Agent Model' – Part II Jul 12 2016 
The “Bribing the Purchasing Agent Model" - Part I Jul 11 2016 
First Eagle Investment Boosts Stake in American Express May 06 2016 

More From Other Websites
Edited Transcript of VAR earnings conference call or presentation 26-Apr-17 9:00pm GMT Apr 28 2017
Varian Medical (VAR) Beats on Earnings and Revenues in Q2 Apr 27 2017
Varian Spotlights World-Leading Systems for Advanced Radiotherapy, Radiosurgery, Brachytherapy and... Apr 27 2017
Varian beats Street 2Q forecasts Apr 26 2017
Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2017 Apr 26 2017
GlassHouse Research: Varian Medical System's Earnings May Be 'Cosmetically Enhanced' Apr 11 2017
Why Is Varian Medical (VAR) Down 2.8% Since the Last Earnings Report? Apr 11 2017
Varian Medical Systems Names New CFO Apr 05 2017
Varian Medical Systems Establishes Direct Operation in South Africa Apr 04 2017
Varian Medical Systems and Elekta Settle Patent Litigation Apr 03 2017
Varian (VAR) Eclipse Software Tops in International Studies Apr 03 2017
Varian Medical Systems Schedules Second Quarter FY2017 News Release and Conference Call Mar 29 2017
Varian Eclipse Customers Achieve Top Scores in International Treatment Plan Studies Mar 29 2017
Why Trump Could Still Be a Threat to Medical Device Stocks Mar 27 2017
Varian Medical Systems Schedules Mid-Year Review with Investors Mar 27 2017
CIO Dedicated to Gender Diversity on Boards Lands a Seat of Her Own Mar 17 2017
Hungary's National Institute of Oncology Upgrades Radiotherapy Equipment With Advanced Varian Linear... Mar 13 2017
[$$] Cancer Test Makers Raise Nearly $1 Billion Mar 01 2017
Varian (VAR): Calypso Tumor Tracking System Now in Brazil Mar 01 2017
José Baselga and Jean-Luc Butel Appointed to Board of Directors of Varian Medical Systems Mar 01 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)